A One Health genomic approach to antimicrobial resistance is essential for generating relevant data for a holistic assessment of the biggest threat to public health

Djordjevic, SP; Morgan, BS

A One Health genomic approach to antimicrobial resistance is essential for generating relevant data for a holistic assessment of the biggest threat to public health

Djordjevic, SP

Morgan, BS

Permalink

Publication Type:: Journal Article
Citation:: Microbiology Australia, 2019, 40 (2), pp. 73 - 76
Issue Date:: 2019-01-01

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

Adobe PDF

Download Accepted Manuscript VersionAdobe PDF (346.73 kB)

View on publisher's site

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Djordjevic, SP https://orcid.org/0000-0001-9301-5372	en_US
dc.contributor.author	Morgan, BS	en_US
dc.date.issued	2019-01-01	en_US
dc.identifier.citation	Microbiology Australia, 2019, 40 (2), pp. 73 - 76	en_US
dc.identifier.issn	1324-4272	en_US
dc.identifier.uri	http://hdl.handle.net/10453/133987
dc.description.abstract	© 2019 Microbiology Australia. All rights reserved. Antimicrobial resistance (AMR) threatensmodernmedicine asweknow it.AMR infectionsmay ultimately beuntreatable and routine surgeries will become inherently risky1. By 2050 more people may die of drug-resistant infections (DRIs) every year than of cancer, which equates to more than 10 million annual deaths globally2 and the World Bank has estimated that AMR could cost the global economy 1 trillion every year after 2030.DRIs alsolead to an increase in the length of hospital stays, the use of more toxic or costly antibiotics and an increased likelihood of death3. BRIC nations (Brazil, Russia, India, China) and socio-economically challenged countries and people who already have higher rates of infectious diseases will feel the greatest impact2. Indeed, AMR has been likened to the 2008 global financial crisis on an annual repeat cycle.Thatis because the effects of AMR are not just confined to the human medical sector. The veterinary sector is also reliant on the availability of antimicrobials to treat infectious diseases in companion and food-producing animals.	en_US
dc.relation.ispartof	Microbiology Australia	en_US
dc.relation.isbasedon	10.1071/MA19021	en_US
dc.title	A One Health genomic approach to antimicrobial resistance is essential for generating relevant data for a holistic assessment of the biggest threat to public health	en_US
dc.type	Journal Article
utslib.citation.volume	2	en_US
utslib.citation.volume	40	en_US
utslib.for	1117 Public Health and Health Services	en_US
utslib.for	0604 Genetics	en_US
utslib.for	0605 Microbiology	en_US
utslib.for	0601 Biochemistry and Cell Biology	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Science
pubs.organisational-group	/University of Technology Sydney/Strength - ithree - Institute of Infection, Immunity and Innovation
utslib.copyright.status	open_access
pubs.issue	2	en_US
pubs.publication-status	Published	en_US
pubs.volume	40	en_US

Abstract:

© 2019 Microbiology Australia. All rights reserved. Antimicrobial resistance (AMR) threatensmodernmedicine asweknow it.AMR infectionsmay ultimately beuntreatable and routine surgeries will become inherently risky1. By 2050 more people may die of drug-resistant infections (DRIs) every year than of cancer, which equates to more than 10 million annual deaths globally2 and the World Bank has estimated that AMR could cost the global economy 1 trillion every year after 2030.DRIs alsolead to an increase in the length of hospital stays, the use of more toxic or costly antibiotics and an increased likelihood of death3. BRIC nations (Brazil, Russia, India, China) and socio-economically challenged countries and people who already have higher rates of infectious diseases will feel the greatest impact2. Indeed, AMR has been likened to the 2008 global financial crisis on an annual repeat cycle.Thatis because the effects of AMR are not just confined to the human medical sector. The veterinary sector is also reliant on the availability of antimicrobials to treat infectious diseases in companion and food-producing animals.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/133987